Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1990 | 12-1989 | 12-1988 | 12-1987 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -21 | -659 | -1,796 | -1,796 |
| Depreciation Amortization | 139 | 227 | 165 | 165 |
| Other Working Capital | 111 | -144 | 125 | 125 |
| Other Operating Activity | 0 | 417 | 0 | 0 |
| Operating Cash Flow | $229 | $-159 | $-1,506 | $-1,506 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -48 | -91 | -204 | -204 |
| Other Investing Activity | -517 | -2,457 | 956 | 956 |
| Investing Cash Flow | $-564 | $-2,548 | $752 | $752 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | -15 | 5,299 | -17 | -17 |
| Financing Cash Flow | $-15 | $5,299 | $-17 | $-17 |
| Beginning Cash Position | 3,223 | 631 | 1,403 | 1,403 |
| End Cash Position | 2,873 | 3,223 | 631 | 631 |
| Net Cash Flow | $-350 | $2,592 | $-772 | $-772 |
| Free Cash Flow | ||||
| Operating Cash Flow | 229 | -159 | -1,506 | -1,506 |
| Free Cash Flow | 229 | -159 | -1,506 | -1,506 |